RPS6KA3 and breast carcinoma: For example, RSK2 has been shown to directly bind [28] and phosphorylate the Estrogen Receptor-α (ERα) at Ser167 [29], resulting in an increased proliferation of Breast Cancer (BCa) cells [28, 30].